BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34846611)

  • 1. Distinct properties of pure- and mixed-type high-grade fetal lung adenocarcinomas by genetic profiling and transcription factor expression.
    Kishikawa S; Hayashi T; Saito T; Takamochi K; Sasa K; Suehara Y; Takahashi F; Sasahara N; Kohsaka S; Suzuki K; Yao T
    Virchows Arch; 2022 Mar; 480(3):609-619. PubMed ID: 34846611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
    Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
    Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic, Immunohistochemical, and Genetic Differences Between High-grade and Low-grade Fetal Adenocarcinomas of the Lung.
    Li Y; Xi SY; Yong JJ; Wu XY; Yang XH; Wang F
    Am J Surg Pathol; 2021 Nov; 45(11):1464-1475. PubMed ID: 34138800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Pathological Characteristics and Prognosis of Lung Adenocarcinoma With High-Grade Fetal Features: A Retrospective Analysis.
    Gu Y; Zhang S; Liang X; Zhao H; Li X; Lu J
    Int J Surg Pathol; 2024 Jun; 32(4):667-678. PubMed ID: 37488988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological, Radiological, and Molecular Features of Primary Lung Adenocarcinoma with Morule-Like Components.
    Wang LL; Ding L; Zhao P; Guan JJ; Ji XB; Zhou XL; Shao SH; Zou YW; Fu WW; Lin DL
    Dis Markers; 2021; 2021():9186056. PubMed ID: 34234879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
    Kishikawa S; Hayashi T; Takamochi K; Ura A; Sasahara N; Saito T; Suzuki K; Yao T;
    Virchows Arch; 2023 Nov; 483(5):699-703. PubMed ID: 37740071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases.
    Morita S; Yoshida A; Goto A; Ota S; Tsuta K; Yokozawa K; Asamura H; Nakajima J; Takai D; Mori M; Oka T; Tamaru J; Itoyama S; Furuta K; Fukayama M; Tsuda H
    Am J Surg Pathol; 2013 Jun; 37(6):924-32. PubMed ID: 23629442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
    Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
    Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and Molecular Characteristics in Low Grade Fetal Adenocarcinoma of the Lung: Two Case Reports and Literature Review.
    Yanagawa N; Uesugi N; Nishiya M; Sugimoto R; Osakabe M; Saitoh H; Maemondo M; Sugai T
    Int J Surg Pathol; 2022 Oct; 30(7):797-803. PubMed ID: 35188818
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features.
    Kawai H; Miura T; Kawamatsu N; Nakagawa T; Shiba-Ishii A; Yoshimoto T; Amano Y; Kihara A; Sakuma Y; Fujita K; Shibano T; Ishikawa S; Ushiku T; Fukayama M; Tsubochi H; Endo S; Hagiwara K; Matsubara D; Niki T
    Virchows Arch; 2024 May; ():. PubMed ID: 38710944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
    Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
    Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
    Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations.
    Hayashi T; Kohsaka S; Takamochi K; Hara K; Kishikawa S; Sano K; Takahashi F; Suehara Y; Saito T; Takahashi K; Suzuki K; Yao T
    Hum Pathol; 2020 Sep; 103():42-51. PubMed ID: 32673682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
    Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
    Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
    Aulakh KS; Chisholm CD; Smith DA; Speights VO
    Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
    Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
    Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
    Xu Y; Zheng M; Wang N; Wang R
    Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component.
    Suzuki M; Kasajima R; Yokose T; Ito H; Shimizu E; Hatakeyama S; Yokoyama K; Yamaguchi R; Furukawa Y; Miyano S; Imoto S; Yoshioka E; Washimi K; Okubo Y; Kawachi K; Sato S; Miyagi Y
    Transl Lung Cancer Res; 2021 Mar; 10(3):1292-1304. PubMed ID: 33889510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.